Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1201 | 953 | 1339 | 1357 | 1886 | 2404 |
Fund Return | 20.12% | -4.71% | 33.88% | 10.72% | 13.53% | 9.17% |
Place in category | 7 | 163 | 20 | 1 | 4 | 31 |
% in Category | 3 | 85 | 14 | 1 | 3 | 29 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fidelity 500 Index Institutional Pr | 592.67B | 20.96 | 9.07 | 12.99 | ||
Fidelity Contrafund | 128.94B | 30.86 | 9.80 | 15.03 | ||
Fidelity Contrafund K | 128.94B | 30.89 | 9.88 | 15.12 | ||
Fidelity Total Market Index Instl b | 100.61B | 19.75 | 7.53 | 12.38 | ||
Fidelity Blue Chip Growth | 62.16B | 28.77 | 6.99 | 17.42 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Vanguard Health Care Adm | 38.75B | 6.13 | 4.16 | 8.41 | ||
Fidelity Select Health Care | 10.35B | 9.86 | -0.54 | 9.10 | ||
T. Rowe Price Health Sciences | 8.77B | 8.60 | -1.25 | 9.86 | ||
Vanguard Health Care Inv | 6.94B | 6.09 | 4.10 | 8.36 | ||
Fidelity Advisor Health Care A | 6.23B | 8.57 | -1.13 | 8.24 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 23.37 | 747.80 | -0.28% | |
Novo Nordisk ADR | US6701002056 | 12.86 | 105.06 | +2.37% | |
AstraZeneca ADR | US0463531089 | 8.22 | 65.63 | +2.13% | |
Bristol-Myers Squibb | US1101221083 | 5.26 | 58.87 | +1.10% | |
UCB | BE0003739530 | 4.92 | 180.00 | +3.36% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Sell | Buy |
Technical Indicators | Strong Sell | Strong Sell | BUY |
Summary | Strong Sell | Strong Sell | Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review